Does BEVACIZUMAB-AWWB Cause Disease progression? 160 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 160 reports of Disease progression have been filed in association with BEVACIZUMAB-AWWB. This represents 3.9% of all adverse event reports for BEVACIZUMAB-AWWB.
160
Reports of Disease progression with BEVACIZUMAB-AWWB
3.9%
of all BEVACIZUMAB-AWWB reports
6
Deaths
8
Hospitalizations
How Dangerous Is Disease progression From BEVACIZUMAB-AWWB?
Of the 160 reports, 6 (3.8%) resulted in death, 8 (5.0%) required hospitalization.
Is Disease progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BEVACIZUMAB-AWWB. However, 160 reports have been filed with the FAERS database.
What Other Side Effects Does BEVACIZUMAB-AWWB Cause?
Off label use (441)
Product storage error (437)
Circumstance or information capable of leading to medication error (346)
Hypertension (187)
Blood pressure increased (163)
Product dose omission issue (158)
Adverse event (143)
Platelet count decreased (118)
Fatigue (104)
Intercepted product administration error (97)
What Other Drugs Cause Disease progression?
RITUXIMAB (7,282)
CYCLOPHOSPHAMIDE (7,100)
DOXORUBICIN (6,165)
VINCRISTINE (5,252)
PREDNISONE (5,096)
BEVACIZUMAB (4,653)
DEXAMETHASONE (4,545)
CARBOPLATIN (4,538)
CAPECITABINE (3,808)
ETOPOSIDE (3,776)
Which BEVACIZUMAB-AWWB Alternatives Have Lower Disease progression Risk?
BEVACIZUMAB-AWWB vs BEVACIZUMAB-BVZR
BEVACIZUMAB-AWWB vs BEVACIZUMAB-MALY
BEVACIZUMAB-AWWB vs BEXAROTENE
BEVACIZUMAB-AWWB vs BEZAFIBRATE
BEVACIZUMAB-AWWB vs BEZLOTOXUMAB